Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Dr. ATUL BATRA

INTRODUCTION

 

Name: ATUL BATRA

Date of birth: 02-01-1986

Designation: Assistant Professor, Department of Medical Oncolocgy

Contact details:     यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. / यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. ;

                               01129575232

 

Links for your research blogs:

https://www.researchgate.net/profile/Atul_Batra2

https://www.linkedin.com/in/atul-batra-94312521

https://scholar.google.co.in/citations?hl=en&user=Cbk97y8AAAAJ

https://www.pubfacts.com/author/Atul+Batra

EDUCATIONAL QUALIFICATIONS

MBBS                                                        Maulana Azad Medical College, Delhi           2008

MD (Medicine)                                          AIIMS            , New Delhi                                         2011

 

BOARD CERTIFICATIONS

DNB (Medical Oncology)                         NBE                                                                2017

MRCP (SCE-Medical Oncology)              RCP                                                                2017

ECMO                                                       ESMO                                                             2015

 

WORK-EXPERIENCE

Senior Resident (Academic)                      AIIMS, New Delhi     January 2013-2015

(Medical Oncology)

Senior Resident (Medical Oncology)        AIIMS, New Delhi     January 2016-November 2016

Assistant Professor (Medical Oncology)   AIIMS, New Delhi     November 2016 - Present

 

AWARDS/ACADEMIC ACHEIVEMENTS

  1. President’s Gold Medal for Best DNB (Medical Oncology)
  2. International CML preceptorship award for 3 weeks clinical training at MSKCC, New York: 30/10/17 to 17/11/2017
  3. Young Investigator Award at SIOP 2017, Washington DC
  4. MASCC Scholarship Award at MASCC 2016, Adelaide
  5. Gold medal (Smt Shakuntala Jolly Award) for Best DM (Medical Oncology) at AIIMS in 2015.
  6. Best Clinical research (Smt. Geeta Mittal Award) in Oncology (Clinical) in AIIMS in 2015.
  7. Young investigator award at SIOP 2015, Capetown (October, 2015).
  8. ESMO Asia Travel Scholarship Award at ESMO Asia, Singapore, 2015.
  9. ESMO Translational Research Fellowship Award at Naples, 2015.
  10. ESMO Preceptorship Travel Awards-       1) Immuno-Oncology, Barcelona, 2014, 2) Prostate Cancer, Prague, 2015, 3) NSCLC, Singapore, 2015
  11. ICMR International Travel Fellowship Award for ASCO 2014, Chicago.
  12. First prize in quiz at International ALL conference, held at Chennai in January 2014.
  13. First prize in a national conference debate on “Intra-arterial chemotherapy in the management of Retinoblastoma: Hope or hype”, conducted in PHOCON-2013 (Pediatric hematology and oncology conference, by IAP) at Delhi (October 2013).
  14. Rank 1 in AIIMS DM (Medical oncology entrance exam), 2011
  15. Rank 1 in AIIMS PG Entrance exam, 2008
  16. Distinction in Physiology andMicrobiology, 2004/2005

 

MAJOR CLINICAL INTERESTS

Dr.Batra is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of Breast cancer, and Genitourinary cancers and routinely takes care of these patients in the OPD and wards. He also actively participates in clinical services for adult haematological malignancies e.g. Hodgkins lymphoma, NHL, Acute and Chronic Leukemias and Multiple myeloma.

MAJOR RESEARCH INTERESTS

1. Breast Cancer

2. Prostate Cancer

3. Renal Cell Cancer

4. Urinary Bladder Cancer

5. Germ Cell Tumor

MAJOR PUBLICATIONS

1.             Pramanik R, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D, Bakhshi S. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors : A Randomized Clinical Trial. JAMA Oncol. 2017 Sep 1;3(9):1222-1227. doi: 10.1001/jamaoncol.2017.0324.

2.             Biwas, B. Rastogi, S. Batra, A. Trastuzumab and Lapatinib in HER2-positive Metastatic Colorectal Cancer. Natl Med J India. 2016 Jul-Aug;29(4):219-220.

3.             Srivastava R, Batra A, Dhawan D, Bakhshi S. Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia. Pediatr Hematol Oncol. 2017 Feb;34(1):29-35. doi: 10.1080/08880018.2016.

4.             Batra A, Kashyap S, Singh L, Bakhshi S. Expression of Sirtuin1 in Retinoblastoma and its correlation with histopathological features. Ocul Oncol Pathol. 2015 Dec;2(2):86-90. doi: 10.1159/000439594.

5.             Batra A, Kain R, Kumari M, Paul R, Dhawan D, Bakhshi S. Parents' Perspective of Quality of Life of Retinoblastoma Survivors. Pediatr Blood Cancer. 2016 Jul;63(7):1287-9. doi: 10.1002/pbc.25982.

6.             Batra A, Bakhshi S.The safety and efficacy of aprepitant in combination with other  antiemetic agents for the prevention of acute and delayed chemotherapy-induced  nausea and vomiting in pediatric patients. Expert Review of Quality of Life in Cancer Care Vol. 1 , Iss. 3,2016. doi: 10.1080/23809000.2016.1174069.

7.             Dabas A, Batra A, Khadgawat R, Jyotsna VP, Bakhshi S. Growth and Endocrinal Abnormalities in Pediatric Langerhans Cell Histiocytosis. Indian J Pediatr. 2016 Jul;83(7):657-60. doi: 10.1007/s12098-016-2053-y.

8.             Batra A, Pushker N, Venkatesh P, Arora T, Tewari R, Bakhshi S. Long-term visual outcomes in retinoblastoma survivors. Clin Transl Oncol. 2016 Oct;18(10):1034-8. doi: 10.1007/s12094-016-1482-4.

9.             Srivastava R, Batra A, Tyagi A, Dhawan D, Ramakrishnan L, Bakhshi S. Adiponectin correlates with obesity: A study of 159 childhood acute leukemia survivors from India.Indian J Cancer. 2015 Apr-Jun;52(2):195-7. doi: 10.4103/0019-509X.175824.

10.         Batra A, Kumari M, Paul R, Patekar M, Dhawan D, , Bakhshi S, Quality of life in retinoblastoma: A cross-sectional study from India. Pediatr Blood Cancer. 2016 Feb;63(2):313-7. doi: 10.1002/pbc.25781.

11.         Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients. J Surg Oncol. 2015 Nov;112(6):662-8. doi: 10.1002/jso.24045.

12.         Batra A, Bakhshi S. Aprepitant for paediatric chemotherapy-induced nausea and vomiting. Lancet Oncol. 2015 Jun;16(6):e259-60. doi: 10.1016/S1470-2045(15)70244-5.

13.         Batra A, Kashyap S, Singh L, Bakhshi S. Expression of FOXO3a in Retinoblastoma and its correlation with histopathological features. Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):95-99. doi: 10.1097/PAI.0000000000000278.

14.         Batra A, Patekar M, Bakhshi S. Short stature in Retinoblastoma. Clin Transl Oncol.2016 Apr;18(4):381-4. doi: 10.1007/s12094-015-1380-1.

15.         Batra A, Thakar A, Bakhshi S. Ototoxicity in retinoblastoma survivors treated with carboplatin  based chemotherapy: A cross-sectional study of 116 patients. Pediatr Blood Cancer. 2015 Nov;62(11):2060. doi: 10.1002/pbc.25618.

16.         Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant as an Add-on Therapy in Children Receiving Highly Emetogenic Chemotherapy: A Randomized, DoubleBlind, Placebo-Controlled Trial. Support Care Cancer. 2015 Nov;23(11):3229-37. doi: 10.1007/s00520-015-2714-9.

17.         Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R.Complete response after autologous stem cell transplant in multiple myeloma.Cancer Med. 2014 Aug;3(4):939-46. doi: 10.1002/cam4.257.

18.         Soneja M, Batra A, Vikram NK, Ahuja  A, Mohan A, Sood R. Actinomycosis and nocardiosis co-infection in chronic  granulomatous disease. J Assoc Physicians India. 2012 Apr;60:66-8.

19.         Singh N, Tripathi R, Tyagi S, Batra A. Antepartum fetal bladder rupture leading to urinary ascitis:attempt to rescue by placement of peritoneo-amniotic shunt. BMJ Case Rep. 2013 Aug 13;2013. pii: bcr2013200021. doi: 10.1136/bcr-2013-200021.

20.         Singh N, Tripathi R, Mala YM, Dixit R, Batra A. Comparison of scar thickness measurements by Trans Vaginal Sonography and Magnetic Resonance Imaging in cases of pregnancy with previousCaesarean section. Do they correlate with actual scar thickness? Journal of Obstetrics & Gynaecology 2013 Nov;33(8):810-3.doi: 10.3109/01443615.2013.823.926.

21.         Singh N, tripathi R, Mala YM, Batra A. Diagnostic dilemma in corneal pregnancy-3DUltrasonography may Aid!!; J Clin Diagn Res. 2015 Jan;9(1):QD12-3. doi: 10.7860/JCDR/2015/6775.5484.

 

ABSTRACTS IN INDEXED JOURNALS:

 

  1. Batra A, Dhawan D, Paul R, Kumari M, Bakhshi S.Improvement in Compliance of Patients with Non-Metastatic Retinoblastoma with Low-Cost Prospective Database and Patient Tracking System: A Study from Tertiary Care Centre in India. Pediatric Blood & Cancer. Volume 64, Issue S3, November 2017. Version of Record online : 1 Sep 2017, doi: 10.1002/pbc.26772.
  2. Pramanik R, Batra A, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Dhawan D, Bakhshi S. Progressive Paediatric Solid Tumours other than Bone-Sarcomas Benefit from Metronomic Chemotherapy: A Subgroup Analysis from a Double Blind Placebo Controlled Randomized Study.  SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233.
  3. Batra A, Bakhshi S, Pushker N.Prognostic Factors in Metastatic Retinoblastoma: A Study of 70 Metastatic Retinoblastoma Patients Treated at a Single Centre in India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233.
  4. Batra A, Kashyap S, Pushker N, Meel R, Bakhshi S.  Retinoblastoma in Children Older Than 6 Years: A Single Centre Study of 58 Patients from India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233.
  5. Batra A, Pushker N, Venkatesh N, Arora T, Tewari R, Bakhshi S. Correlation of Quality of Life and Visual Acuity in Survivors of Bilateral Retinoblastoma Managed with Enucleation of One Eye and Salvage of Other Eye. Support Care Cancer (2016) 24(Suppl 1): 1. https://doi.org/10.1007/s00520-016-3209-z.
  6. Batra A, Kumari M, Paul R, Dhawan D , Bakhshi S. Quality of life in retinoblastoma: Quality of life assessment in retinoblastoma: A cross-sectional study of 122 survivors.10.1200/jco.2015.33.15_suppl.10068 Journal of Clinical Oncology 33, no. 15_suppl (May 2015) 10068-10068.
  7. Batra A, Pushker N, Venkatesh N, Bakhshi S. Visual outcomes and ocular coherence tomography in patients with intraocular retinoblastoma with eye preservation. Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Pages ix156, https://doi.org/10.1093/annonc/mdv535.02
  8. BakhshiS, Batra A, Kumari M, Paul R, Patekar M, Dhawan D. Parents’ Perspective Of Quality Of Life In Retinoblastoma Survivors: A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
  9. Batra A, Kashyap S, Singh L, Bakhshi S. Cytoplasmic Expression of Foxo3a in Retinoblastoma Predicts High Risk Histopathological Features. A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
  10. Batra A, Kashyap S, Singh L, Bakhshi S. Sirtuin1 Expression and Correlation with Histopathological Features In Retinoblastoma. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715. 
  11. Batra A, Thakar A, Patekar M, Bakhshi S. Long-term non-visual outcomes in retinoblastoma survivors (SIOP 2015, Capetown)SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
  12. Batra A, Shrivastava R, Tyagi A , Dhawan D, Ramakrishnan L, Bakhshi S. An Insight Into The Biomarkers Of Obesity In Survivors Of Acute Leukemia. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314.
  13. Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant As An Add-On Therapy In Children Receiving Highly Emetogenic Chemotherapy: A Randomized, Double Blind, Placebo-Controlled Trial. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314.

 

BOOK CHAPTERS

  1. Batra A, Sharma SK. Pulmonary artery hypertension. Medicine update 2012. API
  2. Sharma SK, Batra A. Rheumatoid Lung, Monographs in Rheumatoid arthritis. API

 

MEMBERSHIPS

American Society of Clinical Oncology (ASCO)

European Society of Medical Oncology (ESMO)

International Society of Pediatric Oncology (SIOP)

Young Investigator Group of SIOP(YI-SIOP)

Indian Society of Medical and Pediatric Oncology (ISMPO)

 

PhD Alumini

Alumini

S.NO NAMES MONTH AND YEAR OF PASSING PHOTO
1 DR. GOTTEMUKKALA MURALIK RAJU Feb-99  
2 DR. ASHUTOSH PATHAK May-02  
3 DR. PRATIBHA SHARMA  Jan-10  
4 DR. RASHMI  BHARDWAJ Sep-10  
5 DR. RAKESH VERMA Mar-11  
6 DR. NITIN MATHUR Feb-12  
7 DR. SURENDER KUMAR SHARAWAT May-13  
8 DR.NIVEDITA PATHAK Sep-13  

 

Dr. Raja Pramanik

Name–Dr. Raja Pramanik

 

Qualification: MD (Internal Medicine), DM (Medical Oncology)

 

Designation- Assistant Professor, Department of Medical Oncology

 

Address- Room No. 216, Department of Medical Oncology, 2nd Floor, Dr B.R.A-I.R.C.H ,AIIMS , Ansari Nagar, New Delhi 110029

 

Contact Info :Email – यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.  

 

Academic Career – Dr. Raja Pramanik graduated from the R.G.Kar Medical College of Calcutta University and received his MD degree in Internal Medicine from Patna Medical College, Patna University. He did his senior resident ship in Medical oncology at theDr. B. R. A- IRCH,  AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2016. Caring for cancer patients, research to improve their care and clinical teaching are his greatest passions.

 

Area of Expertise- Dr.Pramanik is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of the Gastro-intestinal cancers (e.g. cancers in the esophagus, stomach, liver, gall bladder, Colon and rectum) and Head and Neck cancers and routinely takes care of these patients in the OPD and wards. He also has keen interest in Clinical Cancer genetics, genetic counselling and research. He also actively participates in clinical services for adult haematological malignancies e.g. Hodgkins lymphoma, NHL, Acute and Chronic Leukemias and Multiple myeloma.

 

 

Research Interests:Esophageal cancer, Clinical Cancer genetics, immuno-oncology, Translational oncology, Metronomic chemotherapy.

 

Awards-

1.            Received the prestigious “Brigid Leventhal Merit Award” in June 2016 at the Annual meeting of American Society of Clinical Oncology(ASCO), in Chicago for the best abstract in Paediatric Oncology by a fellow, as determined by the Program Committee's Paediatrics Subcommittee.

2.            Received IDEA Award (International Development and Education Award) 2016 from American Society of Clinical Oncology, in Chicago, June 2016.

3.            Received “Young oncologists Investigator Award” (YIA) from the International Society of Paediatric Oncology (SIOP) for the year 2016. (Annual Meeting, Dublin, Ireland).

4.            Received Travel Grant from ESMO (European Society for Medical Oncology) to  attendESMO Academy-2016, at Oxford, United Kingdom in August 2016.

5.            Received the“ESMO–Image of the year Award” 2015 from European Society for Medical Oncology.

6.            Received Travel grant from Department of Science & Technology to attend the 15th International Myeloma Workshop in Rome, Sept 2015. (presented two posters on Engraftment syndrome and POEMS syndrome)

7.            Indian Society for Medical and Paediatric Oncology (ISMPO) Gold medal exam 2016, Chennai: 2nd runner-up prize.

8.            Received Travel Grant from European Society for Medical Oncology (ESMO) to attend ESMO Asia Conference in Singapore in December 2015.

9.            Received Travel Grant from European Society for Medical Oncology (ESMO) to attend Preceptorship meet in Gastric Cancer in August 2015 in Brussels, Belgium.

10.          Honours in Anatomy, Physiology, Pharmacology, Preventive & Social Medicine, (MBBS)

11.          Gold medal in ENT, Preventive & Social Medicine(MBBS)

 

 

 

Membership of Professional bodies:

1.            Member: European Society for Medical Oncology, (ESMO).

2.            Member: American Society of Clinical Oncology, (ASCO).

3.            Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)

4.            Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP)

 

 

Selected Publications:       

1.            Pramanik R, Agarwala S, Gupta Y K, Bakhshi S; et al. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial JAMA Oncol. Published online April 6, 2017. doi:10.1001/jamaoncol.2017.0324

2.      Pramanik R, Kumar L. 302PEngraftment syndrome during hematopoietic stem cell transplant: Analysis of 166 transplants from a tertiary care centre. Ann Oncol. 2015 Dec 1;26(suppl 9):ix89–ix89.

3.      Pramanik R, Kumar L. Engraftment Syndrome During Auto HSCT in Plasma Cell Disorders: Retrospective Analysis of Consecutive Cases From a Tertiary Care Centre. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e159–60.

4.      Pramanik R, Kumar L, Cyriac SL. Poems Syndrome: A Retrospective Analysis of Clinicopathological Profile and Treatment Outcomes of 43 Consecutive Cases from a Tertiary Cancer Centre in India. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e198–9.

5.      Pramanik R, Gogia A, Sahoo RK. Manuscript entitled “Neutropenia due to Palbociclib : a word of caution”, with manuscript number ijmpo_158_15, is accepted for publication in the Indian Journal of Medical and paediatric Oncology, IJMPO”(July-Sept 2016 issue)

6.            Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, et al. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med. 2014 Aug;3(4):939–46.

7.            Kumar L, Pramanik R, Kumar S, Bhatla N, Malik S. Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging. Best Pract Res ClinObstetGynaecol. 2015 Aug 1;29(6):790–801.

8.     Gogia A, Khurana S, Paramanik R. Acute Myocardial Infarction after First Dose of Rituximab Infusion. Turk J Hematol. 2014 Mar;31(1):95–6.

9.      Gogia A, Mehta P, Pramanik R, Gupta R .Chronic lymphocytic leukemia with massiveascites: An unusual presenting manifestation. South Asian J Cancer. 2014 Oct-Dec;3(4):235-236 PMID:25422818

10.          Vallonthaiel AG, Kaur K, Jain D, Singh G, Tiwari D, Pramanik R, et al. Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy. ClinGenitourinCancer , 2016 Apr;14(2):e183-6. doi:10.1016/j.clgc.2015.11.001. Epub 2015 Nov 11. PMID:266848127.

11.          Image of the Month: November 2015 | Oncology Diagnosis Project | ESMO [Internet]. [cited 2015 Dec 2]. Available from: http://www.esmo.org/Career-Development/Young-Oncologists-Corner/Image-of-the-Month/November-2015-Image-of-the-Month

12.          Ranjan A, PramanikR,Gupta R, Tanwar P, Bharti S et al ;Chronic Neutrophilic Leukemia: A Rare Chronic Myeloproliferative Disorder. International Journal of Hematology and Oncology 2014, Vol 24, Num 2 Page(s): 145-147       

13.     Gahlot GP, Mridha AR, Sable M, Sharma MC, Pramanik R, Kumar L.Solidpseudopapillary       neoplasm of the ovary with metastases to the omentum and regional lymph nodes.IndianJPatholMicrobiol. 2016 Jul-Sep;59 (3):348-50. doi: 10.4103/0377-4929.188107.PMID: 27510674

14.    Gogia A, Mehta P, Pramanik R, Kumar .Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia. R.Turk J Haematol. 2014 Jun;31(2):203-4. doi: 0.4274/tjh.2013.0270. Epub 2014 Jun 10. PMID:25035685

Dr Lalit Kumar

Dr Lalit Kumar, MD; DM

Professor and Head

Department of Medical Oncology

All India Institute of Medical sciences

(Dr BRA Institute Rotary Cancer Hospital)

New Delhi 110029, India

E-Mail:   medoncoaiims यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

 

 

Research Interests

  • Blood stem cell /Bone marrow transplantation
  • Hematological malignancies, (Multiple myeloma , chronic myeloid leukaemia, Infections)
  • Gynaecological malignancies: Role of neo-adjuvant Chemotherapy

 

DR. AJAY GOGIA

 

Curriculum Vitae

Dr. Ajay Gogia, MD, DM, is an Associate Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his  M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 14 year of working and teaching experience in Medical Oncology and specializes in Breast Cancer & Non-Hodgkin’s Lymphoma patient care and research. He has gained  his  International exposure  in Europe , North America , UK and Canada.His research is well published with more than 100 peer reviewed articles in National and International oncology journals and is well cited. He has received Dronacharya Award in the field of Oncology for his excellence

 

Name                                                    :               Dr. Ajay Gogia

Qualifications                                         :               MBBS,

                                                                             MD (Internal Medicine),

                                                                             DM (Medical Oncology)

 

Current Appointment                    :                          Associate Professor

                                                                            Department of Medical Oncology,

                                                                            Dr. B.R.A, I.R.C.H,

                                                                            All India Institute of Medical Sciences (AIIMS)

                                                                            Ansari Nagar, New Delhi, 110029

 

Nationality                                          :                  Indian 

Education and Qualifications :  

Degree

University

Year

MBBS

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2000

M.D.(Internal Medicine)

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2003

D.M. (Medical Oncology)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2011

  Working place and post : 

Post

University/ INSTITUTE

Year

Senior Residency and D.M ( Medical Oncology)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2006-11

Senior Research Associate

(Pool Officer)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2011-12

Assistant Professor

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2013- 17

Associate Professor

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2017- till date

 

Working&TEACHING experienec in medical oncology: 14 years

 

 Specific Area of Interest

OPD Schedule and timing

Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma especially in low grade lymphoma and CLL

Breast Cancer

 

Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday and Friday (9.30 am, Adult Medical Oncology clinic, Board Room)

Non-Hodgkin Lymphoma  and Chronic lymphocytic leukemia  (CLL)

Thursday (2.00 pm, LL clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

 Fellowship

PLACE

Year

Indian American cancer Association-(IACA) Fellowship

Cleveland Clinic. OHIO, United States of America (USA)

Mentor: Prof. Jame Abraham

2016

European Society Of Medical Oncology (ESMO) Fellowship

Jules Bordet Hospital, Brussels

Mentor: Prof. Martine Piccart

2017

 

MD Anderson Cancer center (MDACC)

MDACC, Houston, Texas,USA

Mentor :Prof. Hagop M.Kantarjian / Prof. Jain

2018

ESMO-  Palliative care visit

 

Princess Margaret Cancer Centre Toronto,Canada

Mentor : Prof. Subratha Banerjee

2019

 

Awards/Honors

PLACE

Year

Best Poster Award  on  Safety and Efficacy of Bendamustine /Rituximab in Indian CLL patients

ESMO, Barcelona

2019

Dronacharya-CME Award  in Oncology

New Delhi by  Minister of Health and welfare ( Mr. Ashwini Chaubey)

2019

 

International Oncology Research   scholarship/grant

PLACE

Year

American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)

Sydney, Australia

2018

INDOX Cancer Research Network

University of Oxford, United Kingdom ( UK)

2012

European Society Of Medical Oncology (ESMO)- Translational unit visit

Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)

2012

European School of Oncology –Master class in clinical Oncology

Ermatingen, Switzerland

2012

 

 

Observer- ship 

PLACE

Year

ESO-Short term in-house observer ship

The Royal Marsden Hospital, London UK

2019

Short term in-house observer ship

Sarah Cannon Center, Nashville, USA

2017

Principle- Investigator ( PI)

A phase III Open label Randomized study to compare the efficacy of Lenalidomide - Rituximab (LR) vsBendamustine –Rituximab (BR) in treatment naïve follicular lymphoma(CTRI/2016/05/006904 [Registered on: 06/05/2016] )

A Prospective, Multicenter, Randomized, Double-blind, Parallel group Study to Compare the Efficacy and Safety of GBR 200 (Similar biologic of Trastuzumab) versus Innovator Trastuzumab, both when Given in Combination with Paclitaxel in Patients Diagnosed with HER2 Positive Metastatic Breast Cancer

Protocol ID: GBR 200-301

A phase II randomized study of the combination of Ribociclib plus goserelin

acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor positive/HER2-negative inoperable locally  advanced or metastatic breast cancer - RIGHT Choice Study.

Co- Investigator ( CO-PI)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Open Label, Randomized Multicenter Trial of Ofatumumab-Chlorambucil combination Vs. ChlorambucilMonotherapy in previously untreated patients with Chronoic Lymphocytic Leukemia”. Protocol: OMB110911. 

OMB110913 - A Phase III, Open Label, Randomized Trial of Ofatumumab added to Fludarabine-Cyclophosphamide Vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia

EGF105485 (TEACH):A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer.

ATLAS (Adjuvant Tamoxifen Long Against Short): A major international trial funded by Oxford University, UK

A randomized, multi-center, open-label, phase III study of Adjuvant Lapatinib, Trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer.” (ALTTO Study)

Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer: axis trial. Sponsored by Pfizer.

A Study of TrastuzumabEmtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA)

A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin AsFirst Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer (Protocol No. ML 25420) 

Setting up Hospital Based Cancer Registries ( HBCRs)  and  Pattern of Care and Survival Studies on Breast Cancer

 

Others

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIM (20 in number)

International scholarship/young investigator award to present oral presentation =3

DM-Medical Oncology Teaching curriculum &  Exam Coordinator: Since 2013

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student  

Active Participation in FREE Medical Camp organized by AIIMS or Govt. of India at LEH and DHARAMSHALA

Regular Participating in patient awareness programme in DOORDARSHAN & RAJSABHA TV

 

 CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES  

  • Members in American Society of Clinical Oncology-(ASCO ID -10476)
  • European Society of Medical Oncology- ESMO-ID-(82716)  

PUBLICATIONS: More than100(Name highlighted)

 

 

In press:

  • Gogia A,  Nigade j,  Desai C,  Govind BK,  Deshmukh C,  Swarup BTrastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer. Indian Journal of Medical and Paediatric Oncology
  • Gupta VG,  Gogia A, Kumar L  , Sharma A, et al Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural …Indian Journal of Medical and Paediatric Oncology
  • Talpua R, Kakkanattu TJ, KumarA,  Gogia A,  WigN.A Case of Idiopathic CD4 Lymphocytopenia (ICL): Immunological Mystery Leading to Storm of Diseases.
  • Journal of Clinical & Diagnostic Research 11 (12)
  • SVS Deo, NK Shukla, A Gogia, DN Sharma, A Jakhetiya, DK MudulyA Comparative Study of Clinical Profile and Relapse Patterns in TRIPLE-NEGATIVE and Non-Triple-Negative Breast Cancer Patients Treated with Curative Intent
  • Indian Journal of Surgical Oncology 8 (3), 291-297

 

POSTER / ORAL PRESENTATION – abstracts  

  • A Gogia, L Kumar, A Sharma, V Raina, R Gupta, L Rani. 1085P Safety and efficacy of bendamustine and rituximab (BR) regimen in Indian chronic lymphocytic leukemia patients. Annals of Oncology 30 (Supplement_5), mdz251. 020
  • A Gogia, L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055
  • N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A Gogia.  CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197
  • S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, Gogia A.ClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257
  • N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235
  • A Kakkar, S Purkait, S Agarwal, S Mallick, A Gogia, AK Karak, MC Sharma.Primary thyroid lymphoma: A series from a tertiary care center in Northern India. Journal of cancer research and therapeutics 15 (3), 669 2019
  • A Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019
  • KR Soti, L Kumar, R Saxena, S Bakhshi, A Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019
  • M Sharma, A Gogia, SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018
  • M Sharma, A Gogia, SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018
  • SK Paikaray, A Gogia, L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018
  • A Biswas, L Kashyap, N Adhikari, A Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018
  • L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA). LEUKEMIA & LYMPHOMA 58, 176-177..2017
  • Bilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management. SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia L Rani, R Gupta, N Mathur, K Singh, A Gogia, D Sundar, L Kumar, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017
  • Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA) L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma. LEUKEMIA & LYMPHOMA 58, 176-177….2017
  • Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. A Jakhetiya, SS Deo, NK Shukla, A Gogia, D Sharma, D Muduly, S Mathur et.al.  ANNALS OF SURGICAL ONCOLOGY 24, S50-S50…2017
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma. SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia. European Journal of Cancer 72, S22…2017
  • 356P Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. VG Gupta, A Gogia, P Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar. Annals of Oncology 27 (suppl_9)..2016
  • 335O Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia et.al.Annals of Oncology 27 (suppl_9).. Page 586  2016
  • 256. A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A Gogia, DN Sharma, et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138
  • Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India. CK Das, L Kumar, A Gogia, R Kaushal. European Journal of Surgical Oncology 42 (9), S138..2016
  • Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.
  • S Taywade, R Kumar, A Behera, N Damle, M Tripathi, A Gogia, CS Bal. Journal of Clinical Oncology 34 (15_suppl), e19073-e19073
  • Autologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A Gogia. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016
  • Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. A Singh, S Purkait, A Gogia, S Mallick. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. R Gupta, L Rani, N Mathur, A Gogia, D Sundar, A Sharma, L Kumar. Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146
  • RR Boya, S Bakhshi, A Gogia, RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72
  • Nasal NK-T cell lymphoma: 10-year experience of a single institute in India. P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A Gogia, T Tvsvgk. Journal of Clinical Oncology 32 (15_suppl), 19536
  • VinodRaina, Ajay Gogia, B. K. Mohanti, S. V. S. Deo, N. K. Shukla, Vishnu kumarSreenivas Breast cancer in the young (≤35 years): A single center study from the All India Institute of Medical Sciences. Journal of Clinical Oncology 31,no.15_suppl10.1200/jco.2013.31.15_suppl.e12539
  • CLINICO‐PATHOLOGICAL PROFILE AND CMYC IMMUNOREACTIVITY OF ALK POSITIVE LARGE B CELL LYMPHOMA: REPORT OF NINE CASES S Mallick, MR Lone, P Ramteke, S Purokait, A Gogia. Hematological Oncology Volume 35, Issue S2,Page 395-6
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Ritu Gupta, Lata Rani, NitinMathur, Ajay Gogia, DuraiSundar, Atul Sharma, Lalit Kumar. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia, DN Sharma, S Thulkar, S Mathur. Hematological Oncology Volume 35, Issue S2, Pages, 395-396
  • Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, Ajay Gogia, Dayanand Sharma, Sandeep R Mathur. Journal of Clinical Oncology Volume 33 e11508
  • Publisher American Society of Clinical Oncology
  • CK Das, A Garg, A Gogia. 533P Docetaxel induced cutaneous toxicity in breast cancer patients.Annals of Oncology Volume 27Issuesuppl_9 …2016
  • Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology
  • NatarajanHarivenkatesh, Lalit Kumar, Sameer Bakhshi, Atul Sharma, MadhulikaKabra, ThirumurthyVelpandian, Ajay Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research
  • Rakesh Reddy, Atul Sharma, Sameer Bakhshi, Ajay Gogia, RanjitSahoo, ChanderPrakashYadav, Lalit Kumar. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.jOURNAL OF CLINICAL ONCOLOGY 34(15_suppl) 8024
  • SmeetaGajendra, Anita Chopra, Suman Kumar, Ajay Gogia,JaganChandramohan, Sameer Bakhshi, Atul Sharma, Lalit Kumar, Rachna Seth, RM PandeyImmunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.LEUKEMIA & LYMPHOMA Volume 54 Pages24-24
  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia, YK Gupta 
  • C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. Sharma.Prognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology Volume 27Issuesuppl_9 …2016 
  • C.K. Das, A. GogiaN.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

 

Book Chapters

Books

  • Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate

 

  • Role ofAutologous Transplant in hematological Malignancies

 

  • Basics of Cancer Biology and Therapy:

Text book of Geriatric Medicine

 

 

Recent Advances in Hematology

 

 Update in Onco-Anaesthesia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

 

 

Top of Page